VERV:Verve Therapeutics Inc - Stock Price Quote and Dividend Data
VERV STOCK PRICE LATEST CLOSE
$3.05
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Verve Therapeutics Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Verve Therapeutics Inc Stock Price Information
52-Week Low/High Stock Price$2.86 - $9.31
Percent Held by Institutions94.48%
Revenue$45,412,000
Net Income$-248,744,000
Cash Flow$-198,537,000
EPS-0.58%
Market Cap$270,827,800
PE Ratio0
PE Ratio to Industry119%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-61.92%
Total Return Last 3 Years-84.45%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 10, 2025
Verve Therapeutics Inc Annual Stock Dividends
No Data available for Payment History.
Verve Therapeutics Inc Dividend Payment History
| No dividends retrieved for VERV |
Verve Therapeutics Inc Other Dividend Details
Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. Co. is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. Co.'s lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering low-density lipoprotein cholesterol (LDL-C), a root cause of atherosclerotic cardiovascular disease (ASCVD). VERVE-101 and VERVE-102 are designed to permanently turn off the PCSK9 gene in the liver and are being developed initially for heterozygous familial hypercholesterolemia (HeFH).
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 11, 2025VERV STOCK PRICE DECREASE: Verve Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.41 to $3.05
Apr. 10, 2025VERV STOCK PRICE INCREASE: Verve Therapeutics Inc on 04-10-2025 increased stock price > 10% from $2.97 to $3.41
Apr. 09, 2025VERV STOCK PRICE DECREASE: Verve Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.34 to $2.97
Apr. 01, 2025VERV STOCK PRICE DECREASE: Verve Therapeutics Inc on 04-01-2025 decreased stock price > 10% from $5.22 to $4.57
Mar. 11, 2025VERV STOCK PRICE DECREASE: Verve Therapeutics Inc on 03-11-2025 decreased stock price > 10% from $6.71 to $5.95
Feb. 15, 2025VERV STOCK PRICE INCREASE: Verve Therapeutics Inc on 02-15-2025 increased stock price > 10% from $7.71 to $8.58
Jan. 23, 2025VERV STOCK PRICE INCREASE: Verve Therapeutics Inc on 01-23-2025 increased stock price > 10% from $6.57 to $7.80
Jan. 17, 2025VERV STOCK PRICE INCREASE: Verve Therapeutics Inc on 01-17-2025 increased stock price > 10% from $5.49 to $6.10
Dec. 21, 2024VERV STOCK PRICE INCREASE: Verve Therapeutics Inc on 12-21-2024 increased stock price > 10% from $5.16 to $5.74
Dec. 10, 2024VERV STOCK PRICE INCREASE: Verve Therapeutics Inc on 12-10-2024 increased stock price > 10% from $6.47 to $7.19
Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00
Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66
Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08
Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06
Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94
Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20
Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12
Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83
Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13
